NCT04118036 2025-08-11Abemaciclib + Pembrolizumab In GlioblastomaDana-Farber Cancer InstitutePhase 2 Withdrawn
NCT05879120 2024-11-20Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent GlioblastomaM.D. Anderson Cancer CenterPhase 2 Withdrawn